November 30, 2022

The Bombay High Court allowed Johnson & Johnson to manufacture baby powder at its Mulund plant in Maharashtra. Johnson & Johnson can make baby powder but not be allowed to sell it, court rules

The Bombay High Court allowed the manufacture of baby powder and ordered its samples to be tested. The baby powder sample will be retested in two weeks. The court, in its order, said the FDA took a sample of the powder and sent it to two government laboratories and a private lab for retesting.

Johnson & Johnson Baby Powder

Bombay High Court Johnson & Johnson (Johnson & Johnson) Pvt Maharashtra K’s Mulund plant was allowed to manufacture baby powder. But a condition has been added to this, the company has to manufacture the powder on its own responsibility. The company has received permission to manufacture the powder, but the product will not be sold or distributed. Because in Maharashtra Food and Drug Administration (FDA) prohibits sale and distribution. Recently, the FDA revoked the Johnson & Johnson plant’s license to manufacture baby powder. With this, the company was ordered to withdraw the product from the market.

The Bombay High Court allowed the manufacture of baby powder and ordered its samples to be tested. The baby powder sample will be retested in two weeks. The court, in its order, said the FDA took a sample of the powder and sent it to two government laboratories and a private lab for retesting. Recently, the Maharashtra government banned Johnson & Johnson’s baby powder citing public interest. Samples taken from the company’s Mulund plant containing baby powder were not found to be of ‘standard quality’.

What is the whole thing?

In December 2018, the FDA conducted a surprise inspection. Among these, quality checks were carried out at Johnson & Johnson’s Pune and Nashik plants. Baby powder samples taken from Mulund plant were not found to be of standard quality. In 2019, a decision came out of this test, which stated that this skin powder for babies does not conform to the norms of IS 5339:2004. After this, a show cause notice was issued to the company under the Drugs and Cosmetics Act, 1940. But the company challenged the move and applied for a retrial.

Show cause notice to company

Under the Drugs Act, Johnson & Johnson was asked in a show-cause notice why the company’s manufacturing license should not be revoked. Also ordered to remove all products from the market. Johnson & Johnson did not accept the government’s report and challenged the decision in the Bombay High Court. It also demanded that the baby powder sample be sent to the referral Central Drugs Laboratory in Kolkata.

Now the Bombay High Court has given its verdict on this matter. It is said that Johnson & Johnson can manufacture the baby powder at its Mulund plant in Maharashtra, but it will have to do so at its own risk. However, the sale and distribution of the company’s products was not allowed.

Also read this



English News Headline: Bombay High Court allows Johnson & Johnson to manufacture baby powder at Maharashtra’s Mulund plant

Leave a Reply

Your email address will not be published. Required fields are marked *